Facial Injectables Market Intelligence Report - Global Forecast to 2027

Facial Injectables Market Intelligence Report - Global Forecast to 2027

The Global Facial Injectables Market is projected to reach USD 26,904.04 million by 2027 from USD 14,068.46 million in 2021, at a CAGR 11.41% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Facial Injectables Market size was estimated at USD 5,224.76 million in 2021 and expected to reach USD 5,769.42 million in 2022, at a CAGR 11.32% to reach USD 9,944.48 million by 2027.
• The Asia-Pacific Facial Injectables Market size was estimated at USD 3,377.41 million in 2021 and expected to reach USD 3,747.26 million in 2022, at a CAGR 11.49% to reach USD 6,488.78 million by 2027.
• The Europe, Middle East & Africa Facial Injectables Market size was estimated at USD 5,466.27 million in 2021 and expected to reach USD 6,055.69 million in 2022, at a CAGR 11.44% to reach USD 10,470.78 million by 2027.

Market Segmentation & Coverage:

The report on facial injectables identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the facial injectables to forecast the revenues and analyze the trends in each of the following sub-markets:

Type:

• Anti-aging Injections
  • Botulinum Toxin A
  • Poly-L-Lactic Acid (PLLA) Micro Particles
• Dermal Fillers
  • Collagen Fillers
  • Hyaluronic Acid
  • Synthetic Fillers

End User:

• Beauty Clinics
• Dermatology Clinics
• Dermatology Research Institutes
• Hospitals

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Connecticut
    • Florida
    • Illinois
    • Maryland
    • Minnesota
    • New Jersey
    • New York
    • Ohio
    • Pennsylvania
    • Texas
    • Washington
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• AbbVie Inc.
• Advanced Dermatology and Cosmetic Surgery
• Antares Pharma, Inc.
• Bausch Health Companies Inc.
• Becton, Dickinson and Company
• Bloomage BioTechnology Corporation Limited
• Eisai Co., Ltd.
• Galderma S.A.
• Johnson & Johnson Services, Inc.
• Medytox Inc.
• Merz Pharma GmbH & Co KGaA
• Novartis AG
• Pfizer Inc.
• Prollenium Medical Technologies Inc.
• Sanofi S.A.
• Sinclair Pharma Group
• Suneva Medical, Inc.

Currency: USD

Base Year: 2021

Estimated Year: 2022

Forecast Year: 2027

Base Year Value: USD 14,068.46 million

Estimated Year Value: USD 15,572.38 million

Forecast Year Value: USD 26,904.04 million

CAGR (%): 11.41%.

Please Note: PDF & Excel + Online Access - 1 Year